Puma Biotechnology第四季度调整后每股收益$0.43超出预期$0.10，销售额$59.10百万超出预期$52.50百万

财报速递02-28
Puma Biotechnology（NASDAQ：PBYI）公布了季度每股收益为$0.43，远超分析师共识预期的$0.10，增幅达330%。与去年同期的每股收益$0.31相比增长了38.71%。公司本季度销售额为$59.10百万，超出分析师共识预期的$52.50百万，增幅为12.57%。但与去年同期的$72.20百万相比，销售额下滑了18.14%。

以上内容来自Benzinga Earnings专栏，原文如下：

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.10 by 330 percent. This is a 38.71 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $59.10 million which beat the analyst consensus estimate of $52.50 million by 12.57 percent. This is a 18.14 percent decrease over sales of $72.20 million the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法